how to avoid weight gain after stopping glp 1 Ozempic, Wegovy, Mounjaro: Maintain Weight loss jabs: What happens

Zepbound's evidence comes from SURMOUNT-1, also published in NEJM (Jastreboff et al., 2022)

Methods Number of Prescriptions and Gross Spending Data: This analysis uses 2019 through 2024 State Drug Utilization Data (SDUD) (downloaded in January 2026)

At JosephCareRX, we prescribe Ozempic not only for its effectiveness in managing type 2 diabetes but also for its additional benefitsreducing cardiovascular risks such as heart attack and stroke in qualifying patients who have existing cardiovascular conditions

1 if they had been prescribed weight loss drugs before Sept

While exenatide (Byetta, Bydureon) was previously approved, these products have been discontinued in the US market